Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

775 recalls, newest first

Class II · Moderate risk

Alprazolam Tab

CGMP Deviations: Downstream recall from Breckenridge Pharmaceuticals, Inc due to potential risk of Cross Contamination.

Terminated Cross-contamination Preferred Pharmaceuticals, Inc. NDC 68788-7596-3 D-0506-2023
Class II · Moderate risk

Alprazolam Tab

CGMP Deviations: Downstream recall from Breckenridge Pharmaceuticals, Inc due to potential risk of Cross Contamination.

Terminated Cross-contamination Preferred Pharmaceuticals, Inc. NDC 68788-7595-3 D-0505-2023
Class II · Moderate risk

Alprazolam Tab

CGMP Deviations: Downstream recall from Breckenridge Pharmaceuticals, Inc due to potential risk of Cross Contamination.

Terminated Cross-contamination Preferred Pharmaceuticals, Inc. NDC 68788-7594-3 D-0504-2023
Class II · Moderate risk

Glimepiride Tablets

CGMP Deviations: recalling drug products following an FDA inspection.

Terminated cGMP deviation Amerisource Health Services LLC NDC 68001-179-00 D-0759-2023
Class II · Moderate risk

Glimepiride Tablets

CGMP Deviations: recalling drug products following an FDA inspection.

Terminated cGMP deviation Amerisource Health Services LLC NDC 68001-178-00 D-0758-2023
Class II · Moderate risk

Glimepiride Tablets

CGMP Deviations: recalling drug products following an FDA inspection.

Terminated cGMP deviation Amerisource Health Services LLC NDC 68001-177-00 D-0757-2023
Class II · Moderate risk

Simvastatin

cGMP deviations

Terminated cGMP deviation Direct Rx NDC 61919-0431-90 D-0486-2023
Class II · Moderate risk

Simvastatin

cGMP deviations

Terminated cGMP deviation Direct Rx NDC 61919-0446-30 D-0485-2023
Class II · Moderate risk

Simvastatin

cGMP deviations

Terminated cGMP deviation Direct Rx NDC 61919-0688-30 D-0484-2023

Recalls by year